Regeneron Pharmaceuticals (REGN) Q1 2020 Earnings

6FebConfirmed
Q2 2019
Q3 2019
Q4 2019
Q1 2020
4.45
5.47
6.48
7.5

Details

Expected EPS
7
Actual EPS
7.5
Surprise EPS
0.5
Surprise Percent
+7.14%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 7.5 per share for Q1 2020.

0 Comments

Share your thoughts